Skip to content

Search

Why RNA?
Doug Hughes, Neotrack

“The RNA team is great. Sam and Kayvon have done an exceptional job working with my companies for over a decade. They deliver on time and I don’t have to spend time getting them up to speed because they already know healthcare and medtech.”

Meet The Team

What Our Clients Say

Board of Advisors

Referral Networks & Partners

Join the RNA Team
Who We Advise
Stig Hansen, Kimia Therapeutics

“I’ve worked with the RNA team for over a decade across my current and previous companies. They are our go to valuation firm for valuation because they know the industry, are responsive and understand the nuances that drive transactions just as much as accounting.”

Venture-Backed Private Companies

Public Companies

Investors

Healthcare Systems & Universities

Executives
Sectors
Marshall Fordyce, Vera Therapeutics

“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”

Biopharmaceuticals

Medtech

Digital Health

Healthcare Services

Technology
What We Deliver

VALUATION OPINIONS

Fairness Opinions

Portfolio Valuation Opinions

Strategic Valuation Opinions

Financial Reporting Valuation Opinions

Tax Reporting Valuation Opinions

TRANSACTION ADVISORY

Benchmarking, Modeling and Analytic Services

Buy-Side Due Diligence & Transaction Support

Sell-Side Due Diligence & Transaction Support

M&A Advisory

Licensing and Partnering Advisory

STRATEGIC ADVISORY

Corporate Strategy

Target Identification and Portfolio Planning

Pricing and Market Access

Market Research and Analysis

Forecasting, Modeling and Simulation

Product Development and Commercialization

Outsourced/Contract Chief Commercial Officer (CCO) Services
Stories

Client Success Stories

Exploring Multiple Strategic Options: A Multi-Track Process

Due Diligence Support (Buy-Side): Fund Manager

Portfolio Modeling Supporting a Financing Transaction

View More
Insights

Latest RNA Insights

Thomas Foster Joins RNA Advisors as Managing Principal

Fairness Opinions: Why Expertise Matters Now More Than Ever in Life Sciences and Healthcare

Scott Winder joins RNA to expand its Life Science Tax and Financial Reporting Valuation Group

Read More
Contact

Contact Us

Chris White, Healthcare Royalty

“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

Contact

Let's Talk!

Name

Company

Phone

Email

Message

I HAVE READ AND AGREE TO THE PRIVACY POLICY.

Mailing Address

200 S. Virginia Street, 8th Floor
Reno, NV 89501

Phone

833-421-1159

Email

info@rnaadvisors.com

Sign Up for Our Newsletter:

Name

Email

Phone: 833-421-1159

Email: info@rnaadvisors.com

Search

Why RNA?
Who We Advise
Sectors
What We Deliver
Stories
RNA Insights
Contact

© 2025 RNA Advisors, LLC. All rights reserved. | Disclaimers | Privacy Policy | Site by CreativePickle.

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.

First Name

Last Name

Email